more emphasis on patients with A fib NOT stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban)

   You'll see more emphasis on patients with A fib NOT stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban).

   Stopping these new anticoagulants...even for a few days...can quickly return patients to their risk of stroke before starting therapy.

   That's because these anticoagulants are short-acting...with half-lives of about 12 hours compared to about 40 hours with warfarin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote